Vai al contenuto principale della pagina
| Autore: |
Reynolds Paul
|
| Titolo: |
Advances in the Treatment of Renal Cell Carcinoma
|
| Pubblicazione: | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica: | 1 online resource (221 p.) |
| Soggetto topico: | Medicine |
| Soggetto non controllato: | artesunate (ART) |
| autophagy | |
| biomarker | |
| biomarkers | |
| ccRCC | |
| chloroquine | |
| clear cell renal cell carcinoma | |
| cysteine cathepsin inhibitors | |
| cysteine cathepsins | |
| evolution | |
| evolutionary trajectory | |
| ferroptosis | |
| genomic signature | |
| growth inhibition | |
| hydroxychloroquine | |
| immune checkpoint inhibitors | |
| immune-based combination therapies | |
| immunotherapy | |
| individualization | |
| kidney cancer | |
| lysosome | |
| metastatic | |
| metastatic renal cell carcinoma | |
| mRCC | |
| network meta-analysis | |
| PD-L1 | |
| predictive | |
| RCC | |
| reactive oxygen species (ROS) | |
| renal cancer | |
| renal cell cancer | |
| renal cell carcinoma | |
| renal cell carcinoma (RCC) | |
| ROC-325 | |
| second line therapy | |
| soluble factors | |
| sunitib resistance | |
| TKIs | |
| Traditional Chinese Medicine (TCM) | |
| transcriptomic analysis | |
| treatment | |
| tyrosine kinase inhibitors | |
| Persona (resp. second.): | StewartGrant D |
| ReynoldsPaul | |
| Sommario/riassunto: | This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon. |
| Titolo autorizzato: | Advances in the Treatment of Renal Cell Carcinoma ![]() |
| Formato: | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910557615503321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |